Functional investigation of troponin with the homozygous HCM mutation, TNNT2 K280N, obtained from an explanted heart

Functional investigation of troponin with the homozygous HCM mutation, TNNT2 K280N, obtained from an explanted heart

Bibliográfalaš dieđut
Váldodahkkit:	Bayliss, C, Messer, A, Leung, M, Ward, D, Van Der Velden, J, Poggesi, C, Redwood, C, Marston, S
Materiálatiipa:	Conference item
Almmustuhtton:	2012

Geahča maid

The HCM-associated cardiac Troponin T mutation K280N causes reduced responsiveness to protein kinase A
Dahkki: Van Der Velden, J, et al.
Almmustuhtton: (2012)

The HCM-Associated Cardiac Troponin T Mutation K280N Increases the Energetic Cost of Tension Generation in Human Cardiac Myofibrils
Dahkki: Ferrara, C, et al.
Almmustuhtton: (2013)

The effect of HCM mutations in troponin T and troponin I on the calcium binding of human cardiac troponin
Dahkki: Redwood, C, et al.
Almmustuhtton: (2001)

Low expression of the K280N TNNT2 mutation is sufficient to increase basal myofilament activation in human hypertrophy cardiomyopathy
Dahkki: Vasco Sequeira, et al.
Almmustuhtton: (2022-09-01)

Mutations in troponin T associated with Hypertrophic Cardiomyopathy increase Ca2+-sensitivity and suppress the modulation of Ca2+-sensitivity by troponin I phosphorylation
Dahkki: Messer, A, et al.
Almmustuhtton: (2016)

A revised method of troponin exchange in permeabilised cardiac trabeculae using vanadate: functional consequences of a HCM-causing mutation in troponin I.
Dahkki: Preston, L, et al.
Almmustuhtton: (2006)

In vitro motility studies of HCM and DCM mutations in cardiac muscle actin
Dahkki: Dyer, E, et al.
Almmustuhtton: (2007)

Myofibrillar Ca(2+) sensitivity is uncoupled from troponin I phosphorylation in hypertrophic obstructive cardiomyopathy due to abnormal troponin T.
Dahkki: Bayliss, C, et al.
Almmustuhtton: (2013)

A Novel Homozygous Intronic Variant in TNNT2 Associates With Feline Cardiomyopathy
Dahkki: James W. McNamara, et al.
Almmustuhtton: (2020-11-01)

Evidence for haploinsufficiency as the mechanism of action of MyBP-C mutations that cause HCM
Dahkki: Carballo, S, et al.
Almmustuhtton: (2008)

HCM and DCM mutations in thin filament proteins have opposite effects on in vitro motility
Dahkki: Marston, S, et al.
Almmustuhtton: (2002)

Cardiac Troponin T (TNNT2) plays a potential oncogenic role in colorectal carcinogenesis
Dahkki: Yifan Liu, et al.
Almmustuhtton: (2023-07-01)

HCM and DCM mutations in thin filament proteins have opposite effects on regulation of contractility in vitro
Dahkki: Redwood, C, et al.
Almmustuhtton: (2003)

Correction: Cardiac Troponin T (TNNT2) plays a potential oncogenic role in colorectal carcinogenesis
Dahkki: Yifan Liu, et al.
Almmustuhtton: (2023-12-01)

HCM and DCM mutations in cardiac thin filament proteins have opposite effects on the regulation of contractility in vitro
Dahkki: Redwood, C, et al.
Almmustuhtton: (2003)

Mouse HCM Model Expression E99K ACTC Mutation Reproduces the Clinical HCM Phenotype
Dahkki: Song, W, et al.
Almmustuhtton: (2009)

Genotype-Driven Pathogenesis of Atrial Fibrillation in Hypertrophic Cardiomyopathy: The Case of Different TNNT2 Mutations
Dahkki: Josè Manuel Pioner, et al.
Almmustuhtton: (2022-04-01)

Investigation of troponin I mutations causing familial hypertrophic cardiomyopathy
Dahkki: Abdulrazzak, H, et al.
Almmustuhtton: (2001)

Functional effects of mutations in troponin T and tropomyosin which cause dilated cardiomyopathy
Dahkki: Robinson, P, et al.
Almmustuhtton: (2003)

Pressure Overload Is Associated With Low Levels of Troponin I and Myosin Binding Protein C Phosphorylation in the Hearts of Patients With Aortic Stenosis
Dahkki: O’neal Copeland, et al.
Almmustuhtton: (2020-03-01)

Increased Myocardial Oxygen Consumption Precedes Contractile Dysfunction in Hypertrophic Cardiomyopathy Caused by Pathogenic TNNT2 Gene Variants
Dahkki: Rahana Y. Parbhudayal, et al.
Almmustuhtton: (2020-04-01)

Comparison of the functional effects of mutations in troponin T which cause dilated and hypertrophic cardiomyopathies
Dahkki: Robinson, P, et al.
Almmustuhtton: (2002)

Nutraceuticals silybin B, resveratrol, and epigallocatechin-3 gallate-bind to cardiac muscle troponin to restore the loss of lusitropy caused by cardiomyopathy mutations in vitro, in vivo, and in silico
Dahkki: Yang, Z, et al.
Almmustuhtton: (2024)

Interaction analyses elucidate the pathophysiology of HCM-causing missense mutations in cardiac myosin binding protein-C.
Dahkki: Moolman-Smook, J, et al.
Almmustuhtton: (2001)

Structure-function relationships of eight mutations in troponin and tropomyosin that cause dilated cardiomyopathy
Dahkki: Mirza, M, et al.
Almmustuhtton: (2004)

DCM troponin C mutant Gly159Asp blunts the response to troponin phosphorylation.
Dahkki: Preston, L, et al.
Almmustuhtton: (2007)

Mutations in fast skeletal troponin I, troponin T and beta-tropomyosin that cause distal arthrogryposis all enhance thin filament activation
Dahkki: Robinson, P, et al.
Almmustuhtton: (2005)

Two mutations in troponin I that cause hypertrophic cardiomyopathy have contrasting effects on cardiac muscle contractility.
Dahkki: Burton, D, et al.
Almmustuhtton: (2002)

A comparative study of mutation screening of sarcomeric genes (MYBPC3, MYH7, TNNT2) using single gene approach versus targeted gene panel next generation sequencing in a cohort of HCM patients in Egypt
Dahkki: Heba Sh. Kassem, et al.
Almmustuhtton: (2017-10-01)

Dilated cardiomyopathy causing mutations in cardiac troponin T (TNT), cardiac troponin C (TNC), and alpha tropomyosin (TM) reduce CA(2+) sensitivity and maximum calcium activation
Dahkki: Redwood, C, et al.
Almmustuhtton: (2004)

Using fluorescence emission spectroscopy to asses the Ca2+ affinity of reconstituted troponin and thin filaments containing cardiomyopathy causing mutations of troponin and alpha-tropomyosin
Dahkki: Robinson, P, et al.
Almmustuhtton: (2007)

Slower calcium handling balances faster cross-bridge cycling in human MYBPC3 HCM
Dahkki: Pioner, JM, et al.
Almmustuhtton: (2023)

Mutations in fast skeletal troponin I, troponin T, and beta-tropomyosin that cause distal arthrogryposis all increase contractile function.
Dahkki: Robinson, P, et al.
Almmustuhtton: (2007)

Investigating the role of uncoupling of Troponin I phosphorylation from changes in myofibrillar Ca2+-sensitivity in the pathogenesis of Cardiomyopathy
Dahkki: Andrew Easton Messer, et al.
Almmustuhtton: (2014-08-01)

Nutraceuticals silybin B, resveratrol, and epigallocatechin-3 gallate-bind to cardiac muscle troponin to restore the loss of lusitropy caused by cardiomyopathy mutations in vitro, in vivo, and in silico
Dahkki: Zeyu Yang, et al.
Almmustuhtton: (2024-12-01)

Altered inhibitory and troponin C-binding activities in cardiac troponin I mutants known to cause hypertrophic cardiomyopathy
Dahkki: Elliott, K, et al.
Almmustuhtton: (2000)

Alterations in thin filament regulation induced by a human cardiac troponin T mutant that causes dilated cardiomyopathy are distinct from those induced by troponin T mutants that cause hypertrophic cardiomyopathy.
Dahkki: Robinson, P, et al.
Almmustuhtton: (2002)

A novel interaction between the C5 and C8 domains of myosin binding protein-C and its modulation by HCM mutations
Dahkki: Flashman, E, et al.
Almmustuhtton: (2002)

Effects of hypertrophic cardiomyopathy mutations in troponin I on contractility of skinned cardiac muscle fibres
Dahkki: Burton, D, et al.
Almmustuhtton: (2002)

Cardiac Overexpression of XIN Prevents Dilated Cardiomyopathy Caused by TNNT2 ΔK210 Mutation
Dahkki: Bin Li, et al.
Almmustuhtton: (2021-06-01)